文献速递贫血与红细胞疾病造血干细胞移植与细胞治疗

供者端粒长度对再生障碍性贫血同胞全合移植生存的影响

Impact of donor telomere length on survival in patients undergoing matched sibling donor transplantation for aplastic anaemia.
PubMed 文献 · Br J Haematol · 2021-10-03

该研究在163例接受同胞全合供者移植的再生障碍性贫血患者中,用实时定量PCR检测移植前患者和供者端粒长度。

要点

  • 供者端粒长度未影响中性粒细胞恢复、植入失败、急性或慢性GVHD。
  • 患者端粒长度与AA严重程度、植入、GVHD及生存均无关联。

核心结论

  • 供者端粒长度较长与再生障碍性贫血同胞全合移植后总生存改善相关。
  • 该关联需在更大规模研究中确认。

研究设计与样本

  • 回顾性研究,纳入163例接受同胞全合供者移植的再生障碍性贫血患者。
  • 采用实时定量PCR检测移植前患者和供者端粒长度。
  • 患者和供者中位年龄分别为24岁和26岁。
  • 主要预处理方案为氟达拉滨联合环磷酰胺,全部接受外周血干细胞移植。

主要发现

  • 植入率89%,原发和继发植入失败合计6%。
  • 急性和慢性GVHD发生率分别为28%和24%。
  • 中位随访37个月时117例(72%)存活。
  • 多因素分析中供者端粒较长、受者年龄和急性GVHD仍为显著因素。

关键数值与推荐

  • 患者端粒长度与AA严重程度、中性粒细胞恢复、植入失败、急性GVHD或慢性GVHD均无关联。
  • 供者端粒长度未影响中性粒细胞恢复、植入失败、急性或慢性GVHD。

临床怎么用

  • 在同胞全合移植供者选择中,供者端粒长度可能作为评估移植后生存的参考指标。
  • 供者端粒长度不影响植入和GVHD风险,其获益主要体现在生存改善。

局限性

  • 研究为单中心回顾性分析,样本量有限。
  • 作者指出结果需在更大规模研究中确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although telomere shortening is seen frequently in patients with aplastic anaemia (AA), there are no data on its association in matched sibling donor (MSD) transplants. We evaluated the effect of pre-transplant telomere length of patients and donors, measured by quantitative real-time polymerase chain reaction in 163 recipients undergoing MSD transplants. The median age of patients and donors was 24 and 26 years, respectively. Fludarabine and cyclophosphamide was the main conditioning regimen used and all received peripheral blood stem cell grafts. Engraftment occurred in 89% with graft failure (primary and secondary) in 6%. Acute and chronic graft-versus-host disease (GVHD) occurred in 28% and 24%, respectively. At a median follow-up of 37 months, 117 patients (72%) were alive. All patients and donors were divided into short and long telomere length based on their median and quartile values. Patient telomere length was not associated with severity of AA, neutrophil recovery, graft failure, acute GVHD or chronic GVHD. Longer donor telomere length was associated with better overall survival [hazard ratio (HR) = 0·2, P = 0·006] but did not influence neutrophil recovery, graft failure, acute or chronic GVHD. The five-year overall survival was significantly better (94·9 ± 3·5% vs 65·4 ± 4·3%, P = 0·002) for donors with long (highest quartile, DTL-HQ) versus short (lower three quartiles, DTL-LQ) telomeres, respectively. On multivariate analysis, longer donor telomere length, recipient age and acute GVHD continued to remain significant. This is the first study demonstrating an association of donor telomere length on overall survival following MSD transplant for AA but it needs to be confirmed in larger studies.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Barade A, Aboobacker F, Korula A, et al. Impact of donor telomere length on survival in patients undergoing matched sibling donor transplantation for aplastic anaemia. Br J Haematol. 2021. PMID: 34605011. doi:10.1111/bjh.17880

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。